David Wilson Email and Phone Number
David Wilson work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
David Wilson personal email
With over 30 years of progressive international experience in the in-vitro diagnostic (IVD) industry, I am a seasoned leader and strategist who has successfully led and supported various initiatives in M&A (buy-side and sell-side), fundraising, business and strategic development, licensing, international sales, marketing, and sales channel management. I have extensive knowledge of, and networks within, domestic and international markets for IVD devices, and a proven track record of delivering value and growth for diverse organizations, from global corporations to angel/VC-funded start-ups. As the Chief Commercial Officer at Avacta, I am part of a dynamic and experienced management team responsible for driving the growth and innovation of the Diagnostics Division, which develops and supplies a broad range of IVD solutions for healthcare professionals. Since joining Avacta in 2019, we have overseen the acquisition of Launch Diagnostics and Coris BioConcept, two strategic moves that have expanded our product portfolio, manufacturing capabilities, and market reach. I have also established and managed key partnerships and collaborations with industry players, regulators, and stakeholders, and contributed to the commercial assessment and launch of new IVD products and technologies. Our mission is to build a global scale IVD business that provides market leading solutions that inform treatment and monitor health and well-being.
-
Senior ConsultantGeorge James ConsultingLondon, England, Gb
-
Chief Commercial Officer, DiagnosticsAvacta Jan 2023 - PresentWetherby, England, GbAvacta's Diagnostics Division, part of LSE AIM-listed Avacta Group plc (LSE:AVCT), develops and supplies a broad range of in-vitro diagnostic (IVD) solutions for healthcare professionals and consumers. The Division is growing rapidly through an M&A strategy to deliver a global scale IVD business providing market leading solutions for healthcare professionals and consumers to inform treatment and monitor health and well-being. In October 2022, Avacta acquired Launch Diagnostics which serves the hospital pathology laboratory market in the UK and Europe. In May 2023, Avacta acquired Coris BioConcept a Belgium-based lateral flow test developer and manufacturer adding a broad range of marketed infectious disease and antimicrobial resistance (AMR) professional-use rapid tests into the Diagnostics Division. -
Commercial Director, DiagnosticsAvacta Aug 2019 - Jan 2023Wetherby, England, Gb
-
Non-Executive DirectorImspex Diagnostics Ltd Sep 2024 - PresentAbercynon, Gb -
Non-Executive DirectorSignpost Cancer Dx America Inc. Jul 2023 - Present
-
Non-Executive DirectorLuas Diagnostics Oct 2023 - PresentLondon, England, Gb -
Chair, Near Patient Testing Working PartyBritish In Vitro Diagnostics Association (Bivda) 2019 - PresentLondon, Gb -
Non-Executive DirectorLinear Diagnostics Limited 2017 - 2024Birmingham, England, GbLinear Diagnostics (LDL) was formed in 2013 as a spin-out of the University of Birmingham. LDL's platform technology utilises a combination of EXPAR and Linear Dichroism to provide rapid, accurate and cost-effective testing at the point-of-care. The Company has developed a duplex test for Chlamydia and Gonorrhea using a single-use, disposable cartridge together with a low cost reader. -
Director, International BusinessHr Healthcare Nov 2017 - Apr 2019York, Pennsylvania, UsDevelopment and execution of international commercial strategy for medical device consumable portfolio entering global markets outside North America. Managing all aspects of market entry strategy including regulatory approvals and establishment and management of indirect sales channels, and delivery of revenue and gross margin targets. -
Board MemberBritish In Vitro Diagnostics Association (Bivda) Oct 2016 - Dec 2017London, Gb
-
Chair, Precision Diagnostics Working PartyBritish In Vitro Diagnostics Association (Bivda) Jan 2015 - Dec 2017London, Gb
-
Head Of International SalesAsuragen Jun 2016 - Nov 2017Austin, Texas, UsLeading a team developing and delivering the commercial strategy for Asuragen's genetic and oncology molecular diagnostic product portfolio (PCR & NGS - based) in all global markets outside North America. Delivered >30% revenue growth in 12 months.Executive Committee - British In Vitro Diagnostics AssociationChair, Precision Diagnostics Working Party - British In Vitro Diagnostics Association -
Director, Commercial Operations, EmeiaAsuragen Jul 2015 - Jun 2016Austin, Texas, UsLed the development and execution of the commercial strategy for the EMEIA (EMEA + India) region for Asuragen's genetic and oncology diagnostic product portfolio. Delivered 25% revenue growth in 12 months.Executive Committee - British In Vitro DIagnostics AssociationChair, Precision Diagnostics Working Party - British In Vitro Diagnostics Association
-
Associate PartnerAlacrita Llp Jan 2012 - Jul 2015Cambridge, Massachusetts, UsLed Alacrita's Dx consulting practice. Alacrita is a transatlantic partnership providing expertise-based consulting services to the pharmaceutical, biotechnology, diagnostics and life science industries. Chair, Precision Diagnostics Working Party at British In Vitro Diagnostics Association (BIVDA)Specialist research and advice to UK Trade and Investment (UKTI) to support growth of export sales for UK-based IVD manufacturing companies in specific markets (6 week interim role)Development and validation of sales channels (direct and/or indirect) to key EU markets for European-based manufacturer of genetic testing/non-invasive prenatal testing (NIPT) kits based on highly multiplexed PCR and next-generation sequencing technologies (6 month interim role) Business planning support for Series B fundraising for early stage European-based manufacturer of infectious disease molecular diagnostic kits (5 month interim role) An ex-US business development strategy for a VC-funded molecular diagnostic company developing a molecular test for autism spectrum disorders Development of a model for assessing the commercial viability of biomarker discoveries for one of the UK’s leading Academic Health Science Centers A Reality Check for a French VC fund on an investment in an early-stage point-of-care Dx business Technology Landscape for early stage US-based Dx company developing neurofibromatosis diagnostics Various Dx-related Technology Assessments for UK & Irish universities -
Vice President, Commercial OperationsMolecular Detection, Inc. Apr 2010 - Mar 2014Wayne , Pa, UsEarly commercial-stage molecular diagnostics company with a focus on the rapid, accurate detection of antibiotic resistant bacteria, including MRSA and other antibiotic resistant bacteria causing sepsis and gastrointestinal infectionsDeveloped, validated and implemented sales channel strategy in EMEAEstablished and ran subsidiary in Europe, which also operated as European Authorized RepresentativeDeveloped strategic and tactical marketing plans for all products, and implemented these through close “hands-on” relationships with distribution partnersLaunched first products to all marketsIdentified KOLs and established early adopters, generating initial sales and catalysts for growthWorked collaboratively with manufacturing, operations, R&D, and finance, across three countries, to determine market driven product requirements, define pipeline and product life-cycle strategiesNegotiated and executed in-licensing agreements for key materials and technologiesEstablished strategic partnerships and alliances to improve product positioning. Implemented key strategic collaboration with global NASDAQ- listed instrument manufacturer to provide complete workflow solutions for hospital laboratoriesActively involved in strategic transaction activity at all levelsCo-authored patent applications related to the differential diagnosis of antibiotic resistant bacteria in clinical samplesReported to US-based CEO -
Founder & DirectorBioscience Business Resources Ltd May 2007 - Mar 2014Specialist IVD/medical device consultancy offering European market entry strategy development and implementation services, and commercial viability assessments of early-stage technologiesIdentified, selected and managed distributors in Europe for early-stage, US-based, IVD & medical device companies. Delivered first sales and sales growth for clients. -
Business Development DirectorGenzyme Diagnostics Oct 2002 - Jan 2007Paris, France, FrIdentified and evaluated investment opportunities (licensing and acquisitions) in European IVD markets, with a focus on innovative products and enabling technologies for quantitative point of care diagnostics. -
International Marketing Manager, DiagnosticsGenzyme Diagnostics Jul 1999 - Oct 2002Paris, France, FrManagement of the marketing function serving markets worldwide outside North and South America. Identifying and screening external product and technology opportunities deriving from countries outside the Americas.- Successfully launched three new products to international markets- Successfully led team that designed and implemented systems to enable CE marking Genzyme branded products and to meet requirements of EU IVD Directive- Consistently delivered marketing objectives supporting aggressive growth of approx. $10-12m annual revenue targets
-
International Sales Manager, Molecular OncologyGenzyme Diagnostics Aug 1997 - Jul 1999Paris, France, FrSole representative in Europe for newly formed, NASDAQ-listed tracking stock. Responsible for generating revenues from sales of licenses and services based on proprietary genomics technology.
-
International Sales Manager, DiagnosticsGenzyme Diagnostics Jul 1996 - Aug 1997Paris, France, FrResponsible for sales of manufactured raw materials and finished products to diagnostic companies in all global markets outside North and South America. - Delivered growth on an annual sales budget of $10m from all channels (OEM and distribution)- Exceeded sales target for newly introduced HDL cholesterol product by over $1m- Management of two Sales Executives
-
Uk Sales Manager, Research ProductsGenzyme Diagnostics Oct 1995 - Jul 1996Paris, France, Fr
-
Non-Executive DirectorSouth East Health Technologies Alliance (Sehta) Mar 2005 - Dec 2006Brighton, East Sussex, GbFounding Director. SEHTA's Board of Directors comprises senior representatives from a cross-section of the health technologies industries based in the south east of England, including SMEs and global corporations. SEHTA was set up and funded by regional government to support the health technologies industries in the south east of England. -
Product Manager, Laboratory DiagnosticsBoehringer Mannheim Uk Aug 1994 - Oct 1995
-
Research Bursar, Epithelial Cell Biology Lab, Imperial Cancer Research FundUcl Jul 1987 - Jul 1992London, Greater London, GbRegistered as a PhD student at UCL, working under the supervision of Professor Avrion Mitchison (UCL) & Dr Joyce Taylor-Papadimitriou (Epithelial Biology Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields Labs, London). Research published (see Publications).
David Wilson Skills
David Wilson Education Details
-
Imperial College Business SchoolExecutive Education - Mergers And Acquisitions -
The Open University Business SchoolMaster Of Business Administration
-
University Of St AndrewsBiochemistry With Microbiology
-
Uc Santa BarbaraBiochemistry & Microbiology
-
City, University Of LondonMathematical Finance And Trading (1St Year Only)
Frequently Asked Questions about David Wilson
What company does David Wilson work for?
David Wilson works for George James Consulting
What is David Wilson's role at the current company?
David Wilson's current role is Senior Consultant.
What is David Wilson's email address?
David Wilson's email address is da****@****ces.com
What schools did David Wilson attend?
David Wilson attended Imperial College Business School, The Open University Business School, University Of St Andrews, Uc Santa Barbara, City, University Of London.
What are some of David Wilson's interests?
David Wilson has interest in Health.
What skills is David Wilson known for?
David Wilson has skills like Biotechnology, Lifesciences, Strategy, Medical Devices, Start Ups, Commercialization, Life Sciences, Pharmaceutical Industry, Product Launch, Business Strategy, Technology Transfer, Hardware Diagnostics.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial